Navigation Links
New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease
Date:10/31/2011

ct, most commonly at the end of the small intestine (the ileum) and beginning of the large intestine (the colon).   If not effectively treated, it may result in the need for surgery and hospitalization. Crohn's disease has been estimated to affect as many as half a million Americans.  People with Crohn's can experience an ongoing cycle of flare-up and remission throughout their lives.

About Cimzia

Certolizumab pegol is the only PEGylated anti-TNF (Tumor Necrosis Factor).  It has a high affinity for human TNF-alpha, selectively neutralizing the pathophysiological effects of TNF-alpha.  Over the past decade, TNF-alpha has emerged as a major target of basic research and clinical investigation.  This cytokine plays a key role in mediating pathological inflammation, and excess TNF-alpha production has been directly implicated in a wide variety of diseases.  The U.S. Food and Drug Administration (FDA) has approved certolizumab pegol for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderate to severe active disease who have had an inadequate response to conventional therapy.  It is also approved for the treatment of adults with moderately to severely active rheumatoid arthritis.  Certolizumab pegol was approved in Switzerland for induction of a clinical response and for the maintenance of a clinical response and remission in patients with active Crohn's disease who have not responded adequately to conventional treatment in September 2007.

Please visit www.cimzia.com for full prescribing information for CIMZIA®.

Important Safety Information

Risk of Serious Infections and Malignancy

Patients treated with CIMZIA are at an increased risk for developing serious infections that may lead to hospitalization or death.  Most patients who developed these infections we
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Cimzia® (certolizumab pegol) Data Showed Rapid Improvement in Signs and Symptoms Predicted Better Long-Term Outcomes in Rheumatoid Arthritis Patients
2. Cimzia® (certolizumab pegol) Data Showed Broad and Rapid Relief From Burden of Symptoms In Rheumatoid Arthritis Patients
3. New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA)
4. Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting
5. UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohns Disease
6. Long-Term Data on Cimzia® (certolizumab pegol) for Moderate to Severe Crohns Disease to be Highlighted at ACG Meeting
7. New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients
8. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
9. CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohns Disease Patients
10. CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohns Patients
11. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014  Publicis Groupe customer engagement agency ... and Healthcare Industry Group Leader, has been featured in ... most inspiring people in the life-sciences industry. Those chosen ... development, marketing, technology, creativity, strategy and medicine. ... partner in its leading Rosetta Consulting practice. In 2012, ...
(Date:8/21/2014)... 21, 2014  Decision Resources Group finds that, ... Brazil and Mexico ... commonly prescribe long-acting beta-agonist (LABA)- and long-acting muscarinic ... within current severe cost/coverage constraints. Therefore, new brands ... to launch in these countries—which will considerably expand ...
(Date:8/21/2014)... MISSION, Kan. , Aug. 21, 2014 /PRNewswire-iReach/ ... Information Trust Alliance (HITRUST) under its Common Security ... ScriptPro,s Enterprise Security and Privacy Manager, "We appreciate ... the level of commitment that this certification signifies. ... compliant." ABOUT THE CSF CERTIFICATION PROCESS: ...
Breaking Medicine Technology:Shannon Hartley Shines in PharmaVOICE 100 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3ScriptPro Achieves HITRUST Certification 2
... Inc. (Nasdaq: MYL ) today affirmed its commitment ... the developing world to high quality, affordable treatment. The company ... exhibition and reception today in Washington D.C. The event is ... Congressional HIV/AIDS Caucus. Mylan President Heather Bresch said: ...
... and GHENT, Belgium, December 1, 2011 ... Antibody Programs into Clinical Development arGEN-X, ... of human monoclonal antibodies from its proprietary SIMPLE Antibody™ ... million (USD 37 million) Series B fundraising round, which ...
Cached Medicine Technology:Mylan Committed to Expanding Access in Developing Countries to High Quality, Affordable HIV/AIDS Treatment 2Mylan Committed to Expanding Access in Developing Countries to High Quality, Affordable HIV/AIDS Treatment 3arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round 2arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round 3arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round 4
(Date:8/22/2014)... (PRWEB) August 22, 2014 The ... Health Clinics are promoting non-invasive screening, risk assessment ... risks of cardiovascular morbidity and mortality, even in ... Deep Vein Thrombosis and Pulmonary Embolus, and Peripheral ... promoting painless, noninvasive screening at accredited facilities at ...
(Date:8/22/2014)... Reacting to naysayers who are being skeptical about the ... PRP therapy LA specialist has firmly stated that the ... practical well researched science and nothing to do with ... medical breakthrough technology which focuses on healing and repair ... , The Managing Director of one of the top ...
(Date:8/22/2014)... OH (PRWEB) August 22, 2014 Teen ... people in Columbus, OH. Unfortunately, most young adults never ... a difference in the community, the new Troubled Teens ... for adolescents seeking to overcome their drug and ... at (614) 902-4644, teens and their parents can speak ...
(Date:8/22/2014)... Aid in Recovery, a full service drug ... a recent bill introduced in the Philippines ... legislator and retired police general. In House Bill 4451, ... rather than imprisonment. Aid in Recovery points to this ... the drug addiction epidemic. , The bill, introduced this ...
(Date:8/21/2014)... 22, 2014 Yoga Darshana Center, the ... region, proudly announces the launch of their newest website ... West Babylon-based yoga studio’s new teacher training program, is ... teachers realize their dreams. , Since 2001, Yoga Darshana ... in the surrounding area a place to learn and ...
Breaking Medicine News(10 mins):Health News:NY Heart Health Clinics Created by Dr. David Greuner and Dr. David Luu of NYC Surgical Associates 2Health News:NY Heart Health Clinics Created by Dr. David Greuner and Dr. David Luu of NYC Surgical Associates 3Health News:MetroMD With The Help Of PRP Therapy Helps People Fight Hip Injuries 2Health News:New Helpline in Columbus Assists Troubled Teen Find Youth Rehab 2Health News:Proposed Legislature in the Philippines Highlights the Need for Rehabilitation, Not Incarceration, for Drug Users, Says Aid in Recovery 2Health News:Proposed Legislature in the Philippines Highlights the Need for Rehabilitation, Not Incarceration, for Drug Users, Says Aid in Recovery 3Health News:Yoga Darshana Center Announces Launch of New Website LongIslandYogaTeacherTraining.com 2
... Findings, Drawn Directly From Brainwaves, That Financial Giants ... 23 As one financial giant after another ... neurological testing company, put the power of brainwaves ... help their battered brands recover.Titled "Money Meltdowns, Minds, ...
... With Special Guest Raphael SaadiqLOS ANGELES, Feb. 23 Sir ... John AIDS Foundation (EJAF) Academy Awards(R) viewing party. The ... Pacific Design Center and was co-sponsored by Chopard, Jo and ... Academy Awards(R) was one of the night,s best attended parties ...
... Heart, Huckabee Dental,s gift of a free day of dentistry, was held ... cleanings. This year,s event was the first annual Dentistry With A ... Southlake, Texas. , ... Southlake, TX (PRWEB) February 23, 2009 -- The ...
... is one of the most cutting edge drug and alcohol detox centers ... recovery center, Tri-Life Health is able to offer a comprehensive program that ... treatment than conventional methods. , ... Fort Collins, CO (PRWEB) February 23, ...
... that the company has been named as one of "KMWorld,s 100 ... ... Los Angeles, Calif. (PRWEB) February 23, 2009 -- Reprints ... the company has been named as one of "KMWorld,s 100 Companies ...
... Effective, Life-saving ProgramsWASHINGTON, Feb. 23 Amid initial indications ... global health, the Global AIDS Alliance is calling on ... Hillary Clinton to keep their campaign commitments to scale ... and accelerate efforts to ensure every child around the ...
Cached Medicine News:Health News:Billions for Bank Bailouts, But How to Rebuild the Brands? NeuroFocus Reveals New Brainwave-Based Solutions 2Health News:Billions for Bank Bailouts, But How to Rebuild the Brands? NeuroFocus Reveals New Brainwave-Based Solutions 3Health News:17th Annual Elton John AIDS Foundation Party Celebrating the Academy Awards Raises Nearly $4 Million 2Health News:17th Annual Elton John AIDS Foundation Party Celebrating the Academy Awards Raises Nearly $4 Million 3Health News:17th Annual Elton John AIDS Foundation Party Celebrating the Academy Awards Raises Nearly $4 Million 4Health News:Dr Timothy Huckabee Free Day of Dental Care Draws a Crowd 2Health News:Tri-Life Health Offers NTR Addiction Recovery Center in Fort Collins, CO 2Health News:Tri-Life Health Offers NTR Addiction Recovery Center in Fort Collins, CO 3Health News:Reprints Desk Named to "KMWorld 100 Companies that Matter in Knowledge Management" List 2Health News:Reprints Desk Named to "KMWorld 100 Companies that Matter in Knowledge Management" List 3Health News:Global AIDS Alliance Sounds Alarm on Potential Budget Cuts 2Health News:Global AIDS Alliance Sounds Alarm on Potential Budget Cuts 3Health News:Global AIDS Alliance Sounds Alarm on Potential Budget Cuts 4
The lower body blanket is designed to be used primarily during surgery on the upper half of the body....
This blanket is ideal for warming the large child or small adult during upper body surgery....
The torso blanket is designed to affix to the lower abdominal area and cover the upper half of the body....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
Medicine Products: